Document Detail

Primary neutrophil-rich, CD30-positive anaplastic large cell lymphoma of the stomach: case report and review of the literature.
MedLine Citation:
PMID:  12619433     Owner:  NLM     Status:  MEDLINE    
Primary T-cell lymphoma of the stomach is a rare disease, most gastric lymphomas being of B-cell type. Here we describe a unique case of primary neutrophil-rich CD30-positive anaplastic large cell lymphoma (ALCL) of the stomach that was treated and cured by combined chemotherapy. According to our literature review, only 7 cases of primary gastric ALCL have been previously reported, none of them being of the neutrophil-rich subtype. Although very peculiar in its histological presentation, which may simulate an inflammatory or carcinomatous process, the natural history as well as the clinical features of this unusual gastric lymphoma does not differ from the other reported cases of gastric ALCL.
M Kahaleh; P Hermans; M Buset; J L Dargent
Related Documents :
11232953 - Malignant lymphoma of mucosa-associated lymphoid tissue of the lacrimal gland: case rep...
11372793 - Lack of cytogenetic abnormalities in castleman's disease.
9182783 - Mosaicism for deletion 1p36.33 in a patient with obesity and hyperphagia.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Acta gastro-enterologica Belgica     Volume:  65     ISSN:  0001-5644     ISO Abbreviation:  Acta Gastroenterol. Belg.     Publication Date:    2002 Oct-Dec
Date Detail:
Created Date:  2003-03-06     Completed Date:  2003-05-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0414075     Medline TA:  Acta Gastroenterol Belg     Country:  Belgium    
Other Details:
Languages:  eng     Pagination:  237-40     Citation Subset:  IM    
Departments of Gastroenterology, Internal Medicine and Pathology, CHU Saint Pierre, Brussels, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD30 / analysis*
Antineoplastic Agents / administration & dosage
Antineoplastic Combined Chemotherapy Protocols*
Cyclophosphamide / administration & dosage
Doxorubicin / administration & dosage
Lymphoma, Large-Cell, Anaplastic / drug therapy,  pathology*
Middle Aged
Neutrophils / immunology*,  pathology
Stomach Neoplasms / drug therapy,  pathology*
Vincristine / administration & dosage
Reg. No./Substance:
0/Antigens, CD30; 0/Antineoplastic Agents; 23214-92-8/Doxorubicin; 50-18-0/Cyclophosphamide; 57-22-7/Vincristine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Economic evaluation of chronic hepatitis C treatment by interferon-ribavirin combination therapy in ...
Next Document:  Cyclospora cayetanensis associated with diarrhea in a patient with idiopathic compensated hepatic ci...